Shareholder Alert: Ademi LLP investigates whether bluebird bio, Inc. is obtaining a Fair Price for its Public Shareholders
1. Ademi LLP investigates BLUE for fiduciary duty breaches in its Carlyle transaction. 2. Tender offer offers $3 per share, raising legal and valuation concerns.